{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:07:58Z","timestamp":1779192478566,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":120,"publisher":"Springer US","isbn-type":[{"value":"9781461408864","type":"print"},{"value":"9781461408871","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-1-4614-0887-1_14","type":"book-chapter","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T09:37:07Z","timestamp":1331026627000},"page":"214-228","source":"Crossref","is-referenced-by-count":30,"title":["FGF21 as a Therapeutic Reagent"],"prefix":"10.1007","author":[{"given":"Yang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexei","family":"Kharitonenkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"453","key":"14_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/249123a0","volume":"249","author":"D Gospodarowicz","year":"1974","unstructured":"Gospodarowicz D. Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 1974; 249(453):123\u2013127.","journal-title":"Nature"},{"issue":"3","key":"14_CR2","doi-asserted-by":"crossref","first-page":"REVIEWS3005","DOI":"10.1186\/gb-2001-2-3-reviews3005","volume":"2","author":"DM Ornitz","year":"2001","unstructured":"Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol 2001; 2(3):REVIEWS3005.","journal-title":"Genome Biol"},{"issue":"2","key":"14_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","volume":"16","author":"VP Eswarakumar","year":"2005","unstructured":"Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005; 16(2):139\u2013149.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"14_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S1097-2765(00)00073-3","volume":"6","author":"J Schlessinger","year":"2000","unstructured":"Schlessinger J, Plotnikov AN, Ibrahimi OA et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 2000; 6(3):743\u2013750.","journal-title":"Mol Cell"},{"issue":"2","key":"14_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1006\/dbio.1993.1205","volume":"158","author":"A Orr-Urtreger","year":"1993","unstructured":"Orr-Urtreger A, Bedford MT, Burakova T et al. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol 1993; 158(2):475\u2013486.","journal-title":"Dev Biol"},{"issue":"4","key":"14_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0092-8674(00)80851-X","volume":"101","author":"AN Plotnikov","year":"2000","unstructured":"Plotnikov AN, Hubbard SR, Schlessinger J et al. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell 2000; 101(4):413\u2013424.","journal-title":"Cell"},{"issue":"5","key":"14_CR7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0092-8674(00)80051-3","volume":"98","author":"AN Plotnikov","year":"1999","unstructured":"Plotnikov AN, Schlessinger J, Hubbard SR et al. Structural basis for FGF receptor dimerization and activation. Cell 1999; 98(5):641\u2013650.","journal-title":"Cell"},{"issue":"5","key":"14_CR8","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0092-8674(00)80252-4","volume":"89","author":"H Kouhara","year":"1997","unstructured":"Kouhara H, Hadari YR, Spivak-Kroizman T et al. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras\/MAPK signaling pathway. Cell 1997; 89(5):693\u2013702.","journal-title":"Cell"},{"issue":"15","key":"14_CR9","doi-asserted-by":"publisher","first-page":"8578","DOI":"10.1073\/pnas.161259898","volume":"98","author":"YR Hadari","year":"2001","unstructured":"Hadari YR, Gotoh N, Kouhara H et al. Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways. Proc Natl Acad Sci USA 2001; 98(15):8578\u20138583.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"14_CR10","doi-asserted-by":"publisher","first-page":"6684","DOI":"10.1073\/pnas.052138899","volume":"99","author":"A Wong","year":"2002","unstructured":"Wong A, Lamothe B, Lee A et al. FRS2 alpha attenuates FGF receptor signaling by Grb2-mediated recruitment of the ubiquitin ligase Cbl. Proc Natl Acad Sci USA 2002; 99(10):6684\u20136689.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"14_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S1097-2765(02)00689-5","volume":"10","author":"I Lax","year":"2002","unstructured":"Lax I, Wong A, Lamothe B et al. The docking protein FRS2alpha controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors. Mol Cell 2002; 10(4):709\u2013719.","journal-title":"Mol Cell"},{"issue":"10","key":"14_CR12","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1128\/MCB.11.10.5068","volume":"11","author":"M Mohammadi","year":"1991","unstructured":"Mohammadi M, Honegger AM, Rotin D et al. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. Mol Cell Biol 1991; 11(10):5068\u20135078.","journal-title":"Mol Cell Biol"},{"issue":"24","key":"14_CR13","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1101\/gad.8.24.3045","volume":"8","author":"CX Deng","year":"1994","unstructured":"Deng CX, Wynshaw-Boris A, Shen MM et al. Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev 1994; 8(24):3045\u20133057.","journal-title":"Genes Dev"},{"issue":"24","key":"14_CR14","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1101\/gad.8.24.3032","volume":"8","author":"TP Yamaguchi","year":"1994","unstructured":"Yamaguchi TP, Harpal K, Henkemeyer M et al. fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes Dev 1994; 8(24):3032\u20133044.","journal-title":"Genes Dev"},{"issue":"15","key":"14_CR15","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1101\/gad.12.15.2332","volume":"12","author":"J Partanen","year":"1998","unstructured":"Partanen J, Schwartz L, Rossant J. Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos. Genes Dev 1998; 12(15):2332\u20132344.","journal-title":"Genes Dev"},{"issue":"4","key":"14_CR16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1242\/dev.125.4.753","volume":"125","author":"X Xu","year":"1998","unstructured":"Xu X, Weinstein M, Li C et al. Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development 1998; 125(4):753\u2013765.","journal-title":"Development"},{"issue":"3","key":"14_CR17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1242\/dev.127.3.483","volume":"127","author":"L Moerlooze De","year":"2000","unstructured":"De Moerlooze L, Spencer-Dene B, Revest JM et al. An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 2000; 127(3):483\u2013492.","journal-title":"Development"},{"issue":"16","key":"14_CR18","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1242\/dev.129.16.3783","volume":"129","author":"VP Eswarakumar","year":"2002","unstructured":"Eswarakumar VP, Monsonego-Ornan E, Pines M et al. The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 2002; 129(16):3783\u20133793.","journal-title":"Development"},{"issue":"6","key":"14_CR19","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","volume":"84","author":"C Deng","year":"1996","unstructured":"Deng C, Wynshaw-Boris A, Zhou F et al. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996; 84(6):911\u2013921.","journal-title":"Cell"},{"issue":"4","key":"14_CR20","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/ng0496-390","volume":"12","author":"JS Colvin","year":"1996","unstructured":"Colvin JS, Bohne BA, Harding GW et al. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet 1996; 12(4):390\u2013397.","journal-title":"Nat Genet"},{"issue":"18","key":"14_CR21","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1242\/dev.125.18.3615","volume":"125","author":"M Weinstein","year":"1998","unstructured":"Weinstein M, Xu X, Ohyama K et al. FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development 1998; 125(18):3615\u20133623.","journal-title":"Development"},{"issue":"11","key":"14_CR22","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00109-004-0571-y","volume":"82","author":"C Dode","year":"2004","unstructured":"Dode C, Hardelin JP. Kallmann syndrome: fibroblast growth factor signaling insufficiency? J Mol Med 2004; 82(11):725\u2013734.","journal-title":"J Mol Med"},{"issue":"10","key":"14_CR23","first-page":"1628","volume":"9","author":"D Macdonald","year":"1995","unstructured":"Macdonald D, Aguiar RC, Mason PJ et al. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review. Leukemia 1995; 9(10):1628\u20131630.","journal-title":"Leukemia"},{"issue":"3","key":"14_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S1535-6108(04)00053-4","volume":"5","author":"S Roumiantsev","year":"2004","unstructured":"Roumiantsev S, Krause DS, Neumann CA et al. Distinct stem cell myeloproliferative\/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations. Cancer Cell 2004; 5(3):287\u2013298.","journal-title":"Cancer Cell"},{"issue":"13","key":"14_CR25","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1182\/blood.V98.13.3778","volume":"98","author":"A Demiroglu","year":"2001","unstructured":"Demiroglu A, Steer EJ, Heath C et al. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Blood 2001; 98(13):3778\u20133783.","journal-title":"Blood"},{"issue":"1","key":"14_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/dvdy.21388","volume":"237","author":"N Itoh","year":"2008","unstructured":"Itoh N, Ornitz DM. Functional evolutionary history of the mouse Fgf gene family. Dev Dyn 2008; 237(1):18\u201327.","journal-title":"Dev Dyn"},{"issue":"5","key":"14_CR27","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.sbi.2005.09.002","volume":"15","author":"M Mohammadi","year":"2005","unstructured":"Mohammadi M, Olsen SK, Goetz R. A protein canyon in the FGF-FGF receptor dimer selects from an a la carte menu of heparan sulfate motifs. Curr Opin Struct Biol 2005; 15(5):506\u2013516.","journal-title":"Curr Opin Struct Biol"},{"issue":"1","key":"14_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/jcp.1041310118","volume":"131","author":"D Moscatelli","year":"1987","unstructured":"Moscatelli D. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J Cell Physiol 1987; 131(1):123\u2013130.","journal-title":"J Cell Physiol"},{"issue":"4","key":"14_CR29","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1083\/jcb.111.4.1651","volume":"111","author":"R Flaumenhaft","year":"1990","unstructured":"Flaumenhaft R, Moscatelli D, Rifkin DB. Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor. J Cell Biol 1990; 111(4):1651\u20131659.","journal-title":"J Cell Biol"},{"issue":"6","key":"14_CR30","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI23606","volume":"115","author":"A Kharitonenkov","year":"2005","unstructured":"Kharitonenkov A, Shiyanova TL, Koester A et al. FGF-21 as a novel metabolic regulator. J Clin Invest 2005; 115(6):1627\u20131635.","journal-title":"J Clin Invest"},{"issue":"11","key":"14_CR31","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 2001; 98(11):6500\u20136505.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"14_CR32","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1365-2796.2006.01731.x","volume":"260","author":"T Lund\u00e5sen","year":"2006","unstructured":"Lund\u00e5sen T, G\u00e4lman C, Angelin B et al. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med 2006; 260(6):530\u2013536.","journal-title":"J Intern Med"},{"issue":"18","key":"14_CR33","doi-asserted-by":"publisher","first-page":"7432","DOI":"10.1073\/pnas.0701600104","volume":"104","author":"Y Ogawa","year":"2007","unstructured":"Ogawa Y, Kurosu H, Yamamoto M et al. BetaKlotho is required for metabolic activity of fibroblast growth factor 21. Proc Natl Acad Sci USA 2007; 104(18):7432\u20137437.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7120","key":"14_CR34","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I, Yamazaki Y, Shimada T et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 2006; 444(7120):770\u2013774.","journal-title":"Nature"},{"issue":"24","key":"14_CR35","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1242\/dev.128.24.5109","volume":"128","author":"A Bhushan","year":"2001","unstructured":"Bhushan A, Itoh N, Kato S et al. Fgf10 is essential for maintaining the proliferative capacity of epithelial progenitor cells during early pancreatic organogenesis. Development 2001; 128(24):5109\u20135117.","journal-title":"Development"},{"issue":"3","key":"14_CR36","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1006\/bbrc.2000.3721","volume":"277","author":"H Ohuchi","year":"2000","unstructured":"Ohuchi H, Hori Y, Yamasaki M et al. FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem Biophys Res Commun 2000; 277(3):643\u2013649.","journal-title":"Biochem Biophys Res Commun"},{"key":"14_CR37","doi-asserted-by":"publisher","first-page":"12119","DOI":"10.1074\/jbc.275.16.12119","volume":"27516","author":"M Konishi","year":"2000","unstructured":"Konishi M, Mikami T, Yamasaki M et al. Fibroblast growth factor-16 is a growth factor for embryonic brown adipocytes. J Biol Chem 2000; 275(16):12119\u201312122.","journal-title":"J Biol Chem"},{"issue":"3","key":"14_CR38","doi-asserted-by":"publisher","first-page":"E964","DOI":"10.1152\/ajpendo.00089.2006","volume":"292","author":"HD Sun","year":"2007","unstructured":"Sun HD, Malabunga M, Tonra JR et al. Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys. Am J Physiol Endocrinol Metab 2007; 292(3):E964\u2013E976.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6814","key":"14_CR39","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/35048589","volume":"408","author":"AW Hart","year":"2000","unstructured":"Hart AW, Baeza N, Apelqvist A et al. Attenuation of FGF signalling in mouse beta-cells leads to diabetes. Nature 2000; 408(6814):864\u2013868.","journal-title":"Nature"},{"issue":"4","key":"14_CR40","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.4049\/jimmunol.167.4.1954","volume":"167","author":"JM Revest","year":"2001","unstructured":"Revest JM, Suniara RK, Kerr K et al. Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb. J Immunol 2001; 167(4):1954\u20131961.","journal-title":"J Immunol"},{"issue":"6","key":"14_CR41","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/emboj\/17.6.1642","volume":"17","author":"G Celli","year":"1998","unstructured":"Celli G, LaRochelle WJ, Mackem S et al. Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J 1998; 17(6):1642\u20131655.","journal-title":"EMBO J"},{"issue":"6","key":"14_CR42","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1073\/pnas.062321799","volume":"99","author":"L Elghazi","year":"2002","unstructured":"Elghazi L, Cras-M\u00e9neur C, Czernichow P et al. Role for FGFR2IIIb-mediated signals in controlling pancreatic endocrine progenitor cell proliferation. Proc Natl Acad Sci USA 2002; 99(6):3884\u20133889.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"14_CR43","doi-asserted-by":"publisher","first-page":"15482","DOI":"10.1074\/jbc.275.20.15482","volume":"275","author":"C Yu","year":"2000","unstructured":"Yu C, Wang F, Kan M et al. Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J Biol Chem 2000; 275(20):15482\u201315489.","journal-title":"J Biol Chem"},{"issue":"10","key":"14_CR44","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.2337\/db07-0648","volume":"56","author":"X Huang","year":"2007","unstructured":"Huang X, Yang C, Luo Y et al. FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver. Diabetes 2007; 56(10):2501\u20132510.","journal-title":"Diabetes"},{"issue":"17","key":"14_CR45","doi-asserted-by":"publisher","first-page":"11110","DOI":"10.1074\/jbc.M808747200","volume":"284","author":"DJ Shin","year":"2009","unstructured":"Shin DJ, Osborne TF. FGF15\/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action. J Biol Chem 2009; 284(17):11110\u201311120.","journal-title":"J Biol Chem"},{"issue":"9","key":"14_CR46","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1128\/MCB.02249-06","volume":"27","author":"R Goetz","year":"2007","unstructured":"Goetz R, Beenken A, Ibrahimi OA et al. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol 2007; 27(9):3417\u20133428.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"14_CR47","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/bi035320k","volume":"43","author":"NJ Harmer","year":"2004","unstructured":"Harmer NJ, Pellegrini L, Chirgadze D et al. The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity. Biochemistry 2004; 43(3):629\u2013640.","journal-title":"Biochemistry"},{"issue":"1\u20132","key":"14_CR48","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0925-4773(00)00439-1","volume":"98","author":"S Ito","year":"2000","unstructured":"Ito S, Kinoshita S, Shiraishi N et al. Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel Klotho family protein. Mech Dev 2000; 98(1\u20132):115\u2013119.","journal-title":"Mech Dev"},{"issue":"12","key":"14_CR49","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1210\/me.2003-0048","volume":"17","author":"H Tsujikawa","year":"2003","unstructured":"Tsujikawa H, Kurotaki Y, Fujimori T et al. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 2003; 17(12):2393\u20132403.","journal-title":"Mol Endocrinol"},{"issue":"13","key":"14_CR50","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1101\/gad.1083503","volume":"17","author":"JA Holt","year":"2003","unstructured":"Holt JA, Luo G, Billin AN et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 2003; 17(13):1581\u20131591.","journal-title":"Genes Dev"},{"issue":"4","key":"14_CR51","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","volume":"2","author":"T Inagaki","year":"2005","unstructured":"Inagaki T, Choi M, Moschetta A et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2005; 2(4):217\u2013225.","journal-title":"Cell Metab"},{"issue":"5","key":"14_CR52","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1210\/en.143.5.1741","volume":"143","author":"E Tomlinson","year":"2002","unstructured":"Tomlinson E, Fu L, John L et al. Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 2002; 143(5):1741\u20131747.","journal-title":"Endocrinology"},{"issue":"8","key":"14_CR53","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1172\/JCI23076","volume":"115","author":"S Ito","year":"2005","unstructured":"Ito S, Fujimori T, Furuya A et al. Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho. J Clin Invest 2005; 115(8):2202\u20132208.","journal-title":"J Clin Invest"},{"issue":"1","key":"14_CR54","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","volume":"1492","author":"T Nishimura","year":"2000","unstructured":"Nishimura T, Nakatake Y, Konishi M et al. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 2000; 1492(1):203\u2013206.","journal-title":"Biochim Biophys Acta"},{"issue":"19","key":"14_CR55","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/hmg\/ddh235","volume":"13","author":"OA Ibrahimi","year":"2004","unstructured":"Ibrahimi OA, Zhang F, Eliseenkova AV et al. Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. Hum Mol Genet 2004; 13(19):2313\u20132324.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"14_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcp.21357","volume":"215","author":"A Kharitonenkov","year":"2008","unstructured":"Kharitonenkov A, Dunbar JD, Bina HA et al. FGF-21\/FGF-21 receptor interaction and activation is determined by betaKlotho. J Cell Physiol 2008; 215(1):1\u20137.","journal-title":"J Cell Physiol"},{"issue":"4","key":"14_CR57","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1210\/me.2007-0313","volume":"22","author":"M Suzuki","year":"2008","unstructured":"Suzuki M, Uehara Y, Motomura-Matsuzaka K et al. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. Mol Endocrinol 2008; 22(4):1006\u20131014.","journal-title":"Mol Endocrinol"},{"issue":"37","key":"14_CR58","doi-asserted-by":"publisher","first-page":"26687","DOI":"10.1074\/jbc.M704165200","volume":"282","author":"H Kurosu","year":"2007","unstructured":"Kurosu H, Choi M, Ogawa Y et al. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem 2007; 282(37):26687\u201326695.","journal-title":"J Biol Chem"},{"issue":"4","key":"14_CR59","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1152\/physrev.2000.80.4.1373","volume":"80","author":"H Murer","year":"2000","unstructured":"Murer H, Hernando N, Forster I et al. Proximal tubular phosphate reabsorption: molecular mechanisms. Physiol Rev 2000; 80(4):1373\u20131409.","journal-title":"Physiol Rev"},{"issue":"5","key":"14_CR60","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci M, Collins MT, Fedarko NS et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 2003; 112(5):683\u2013692.","journal-title":"J Clin Invest"},{"issue":"2","key":"14_CR61","first-page":"201","volume":"7","author":"K Wikvall","year":"2001","unstructured":"Wikvall K. Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review). Int J Mol Med 2001; 7(2):201\u2013209.","journal-title":"Int J Mol Med"},{"issue":"4","key":"14_CR62","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 2004; 113(4):561\u2013568.","journal-title":"J Clin Invest"},{"issue":"7","key":"14_CR63","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","volume":"23","author":"D Sitara","year":"2004","unstructured":"Sitara D, Razzaque MS, Hesse M et al. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 2004; 23(7):421\u2013432.","journal-title":"Matrix Biol"},{"issue":"2","key":"14_CR64","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1210\/en.143.2.683","volume":"143","author":"T Yoshida","year":"2002","unstructured":"Yoshida T, Fujimori T, Nabeshima Y. Mediation of unusually high concentrations of 1, 25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene. Endocrinology 2002; 143(2):683\u2013689.","journal-title":"Endocrinology"},{"issue":"6","key":"14_CR65","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","volume":"5","author":"T Inagaki","year":"2007","unstructured":"Inagaki T, Dutchak P, Zhao G et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 2007; 5(6):415\u2013425.","journal-title":"Cell Metab"},{"issue":"12","key":"14_CR66","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.febslet.2008.04.038","volume":"582","author":"P Arner","year":"2008","unstructured":"Arner P, Pettersson A, Mitchell PJ et al. FGF21 attenuates lipolysis in human adipocytes\u2014a possible link to improved insulin sensitivity. FEBS Lett 2008; 582(12):1725\u20131730.","journal-title":"FEBS Lett"},{"issue":"6","key":"14_CR67","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","volume":"5","author":"MK Badman","year":"2007","unstructured":"Badman MK, Pissios P, Kennedy AR et al. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 2007; 5(6):426\u2013437.","journal-title":"Cell Metab"},{"issue":"1","key":"14_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcp.20847","volume":"210","author":"JS Moyers","year":"2007","unstructured":"Moyers JS, Shiyanova TL, Mehrbod F et al. Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling. J Cell Physiol 2007; 210(1):1\u20136.","journal-title":"J Cell Physiol"},{"issue":"2","key":"14_CR69","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1124\/mol.108.044826","volume":"74","author":"ES Muise","year":"2008","unstructured":"Muise ES, Azzolina B, Kuo DW et al. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states. Mol Pharmacol 2008; 74(2):403\u2013412.","journal-title":"Mol Pharmacol"},{"issue":"1","key":"14_CR70","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1128\/MCB.00992-07","volume":"28","author":"H Wang","year":"2008","unstructured":"Wang H, Qiang L, Farmer SR. Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes. Mol Cell Biol 2008; 28(1):188\u2013200.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"14_CR71","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2165\/00063030-200822010-00004","volume":"22","author":"A Kharitonenkov","year":"2008","unstructured":"Kharitonenkov A, Shanafelt AB. Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases. BioDrugs 2008; 22(1):37\u201344.","journal-title":"BioDrugs"},{"issue":"27","key":"14_CR72","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1016\/j.febslet.2008.10.021","volume":"582","author":"Y Izumiya","year":"2008","unstructured":"Izumiya Y, Bina HA, Ouchi N et al. FGF21 is an Akt-regulated myokine. FEBS Lett 2008; 582(27): 3805\u20133810.","journal-title":"FEBS Lett"},{"issue":"2","key":"14_CR73","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cmet.2007.11.003","volume":"7","author":"Y Izumiya","year":"2008","unstructured":"Izumiya Y, Hopkins T, Morris C et al. Fast\/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab 2008; 7(2):159\u2013172.","journal-title":"Cell Metab"},{"issue":"2","key":"14_CR74","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bbrc.2007.06.068","volume":"360","author":"T Lund\u00e5sen","year":"2007","unstructured":"Lund\u00e5sen T, Hunt MC, Nilsson LM et al. PPARalpha is a key regulator of hepatic FGF21. Biochem Biophys Res Commun 2007; 360(2):437\u2013440.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"14_CR75","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.2337\/db05-1435","volume":"55","author":"W Wente","year":"2006","unstructured":"Wente W, Efanov AM, Brenner M et al. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1\/2 and Akt signaling pathways. Diabetes 2006; 55(9):2470\u20132478.","journal-title":"Diabetes"},{"issue":"9","key":"14_CR76","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1210\/en.2002-220174","volume":"143","author":"G Leibowitz","year":"2002","unstructured":"Leibowitz G, U\u00e7kaya G, Oprescu AI et al. Glucose-regulated proinsulin gene expression is required for adequate insulin production during chronic glucose exposure. Endocrinology 2002; 143(9):3214\u20133220.","journal-title":"Endocrinology"},{"issue":"5","key":"14_CR77","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1172\/JCI420","volume":"101","author":"LC Bollheimer","year":"1998","unstructured":"Bollheimer LC, Skelly RH, Chester MW et al. Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest 1998; 101(5):1094\u20131101.","journal-title":"J Clin Invest"},{"issue":"1","key":"14_CR78","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cmet.2008.05.006","volume":"8","author":"T Inagaki","year":"2008","unstructured":"Inagaki T, Lin VY, Goetz R et al. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab 2008; 8(1):77\u201383.","journal-title":"Cell Metab"},{"issue":"12","key":"14_CR79","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1210\/en.2008-0816","volume":"149","author":"T Coskun","year":"2008","unstructured":"Coskun T, Bina HA, Schneider MA et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 2008; 149(12):6018\u20136027.","journal-title":"Endocrinology"},{"issue":"1","key":"14_CR80","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2337\/db08-0392","volume":"58","author":"J Xu","year":"2009","unstructured":"Xu J, Lloyd DJ, Hale C et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure and improves insulin sensitivity in diet-induced obese mice. Diabetes 2009; 58(1):250\u2013259.","journal-title":"Diabetes"},{"issue":"9","key":"14_CR81","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1210\/en.2009-0221","volume":"150","author":"ED Berglund","year":"2009","unstructured":"Berglund ED, Li CY, Bina HA et al. Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity. Endocrinology 2009; 150(9):4084\u20134093.","journal-title":"Endocrinology"},{"issue":"12","key":"14_CR82","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/mc.20241","volume":"45","author":"X Huang","year":"2006","unstructured":"Huang X, Yu C, Jin C et al. Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis. Mol Carcinog 2006; 45(12):934\u2013942.","journal-title":"Mol Carcinog"},{"key":"14_CR83","doi-asserted-by":"crossref","unstructured":"Xu J, Stanislaus S, Chinookoswong N et al. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin resistant mouse models\u2014Association with liver and adipose tissue effects. Am J Physiol Endocrinol Metab 2009.","DOI":"10.1152\/ajpendo.00348.2009"},{"issue":"15","key":"14_CR84","doi-asserted-by":"publisher","first-page":"10023","DOI":"10.1074\/jbc.M808818200","volume":"284","author":"S Bhatnagar","year":"2009","unstructured":"Bhatnagar S, Damron HA, Hillgartner FB. Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis. J Biol Chem 2009; 284(15):10023\u201310033.","journal-title":"J Biol Chem"},{"issue":"48","key":"14_CR85","doi-asserted-by":"publisher","first-page":"33304","DOI":"10.1074\/jbc.M803319200","volume":"283","author":"X Wu","year":"2008","unstructured":"Wu X, Lemon B, Li X et al. C-terminal tail of FGF19 determines its specificity toward Klotho coreceptors. J Biol Chem 2008; 283(48):33304\u201333309.","journal-title":"J Biol Chem"},{"issue":"2","key":"14_CR86","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/jcp.21675","volume":"219","author":"R Micanovic","year":"2009","unstructured":"Micanovic R, Raches DW, Dunbar JD et al. Different roles of N-and C-termini in the functional activity of FGF21. J Cell Physiol 2009; 219(2):227\u2013234.","journal-title":"J Cell Physiol"},{"issue":"1","key":"14_CR87","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.febslet.2008.11.023","volume":"583","author":"J Yie","year":"2009","unstructured":"Yie J, Hecht R, Patel J et al. FGF21 N-and C-termini play different roles in receptor interaction and activation. FEBS Lett 2009; 583(1):19\u201324.","journal-title":"FEBS Lett"},{"issue":"9","key":"14_CR88","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1359\/jbmr.080417","volume":"23","author":"Y Yamazaki","year":"2008","unstructured":"Yamazaki Y, Tamada T, Kasai N et al. Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23. J Bone Miner Res 2008; 23(9):1509\u20131518.","journal-title":"J Bone Miner Res"},{"issue":"11","key":"14_CR89","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nm1501","volume":"12","author":"M Choi","year":"2006","unstructured":"Choi M, Moschetta A, Bookout AL et al. Identification of a hormonal basis for gallbladder filling. Nat Med 2006; 12(11):1253\u20131255.","journal-title":"Nat Med"},{"issue":"6","key":"14_CR90","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1016\/S0002-9440(10)61177-7","volume":"160","author":"K Nicholes","year":"2002","unstructured":"Nicholes K, Guillet S, Tomlinson E et al. A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. Am J Pathol 2002; 160(6):2295\u20132307.","journal-title":"Am J Pathol"},{"issue":"37","key":"14_CR91","doi-asserted-by":"publisher","first-page":"28918","DOI":"10.1074\/jbc.M910350199","volume":"275","author":"T Hashimoto","year":"2000","unstructured":"Hashimoto T, Cook WS, Qi C et al. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J Biol Chem 2000; 275(37):28918\u201328928.","journal-title":"J Biol Chem"},{"issue":"11","key":"14_CR92","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/JCI6223","volume":"103","author":"S Kersten","year":"1999","unstructured":"Kersten S, Seydoux J, Peters JM et al. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 1999; 103(11):1489\u20131498.","journal-title":"J Clin Invest"},{"issue":"13","key":"14_CR93","doi-asserted-by":"publisher","first-page":"7473","DOI":"10.1073\/pnas.96.13.7473","volume":"96","author":"TC Leone","year":"1999","unstructured":"Leone TC, Weinheimer CJ, Kelly DP. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 1999; 96(13):7473\u20137478.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"14_CR94","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1016\/j.peptides.2007.10.007","volume":"28","author":"H Hsuchou","year":"2007","unstructured":"Hsuchou H, Pan W, Kastin AJ. The fasting polypeptide FGF21 can enter brain from blood. Peptides 2007; 28(12):2382\u20132386.","journal-title":"Peptides"},{"issue":"1","key":"14_CR95","doi-asserted-by":"publisher","first-page":"E76","DOI":"10.1152\/ajpendo.00014.2009","volume":"297","author":"T Uebanso","year":"2009","unstructured":"Uebanso T, Taketani Y, Fukaya M et al. Hypocaloric high-protein diet improves fatty liver and hypertriglyceridemia in sucrose-fed obese rats via two pathways. Am J Physiol Endocrinol Metab 2009; 297(1):E76\u2013E84.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"14_CR96","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00424-008-0461-1","volume":"456","author":"M Palou","year":"2008","unstructured":"Palou M, Priego T, S\u00e1nchez J et al. Sequential changes in the expression of genes involved in lipid metabolism in adipose tissue and liver in response to fasting. Pflugers Arch 2008; 456(5):825\u2013836.","journal-title":"Pflugers Arch"},{"key":"14_CR97","doi-asserted-by":"crossref","unstructured":"Badman MK, Koester A, Flier JS et al. Fibroblast Growth Factor 21-Deficient Mice Demonstrate Impaired Adaptation to Ketosis. Endocrinology 2009; 150(11):Epub as doi:10.1210\/en.2009-0523.","DOI":"10.1210\/en.2009-0523"},{"issue":"2","key":"14_CR98","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bcp.2004.03.004","volume":"68","author":"SA Sch\u00e4fer","year":"2004","unstructured":"Sch\u00e4fer SA, Hansen BC, V\u00f6lkl A et al. Biochemical and morphological effects of K-111, a peroxisome proliferator-activated receptor (PPAR)alpha activator, in nonhuman primates. Biochem Pharmacol 2004; 68(2):239\u2013251.","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"14_CR99","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1210\/en.2003-1103","volume":"145","author":"SV Angeloni","year":"2004","unstructured":"Angeloni SV, Glynn N, Ambrosini G et al. Characterization of the rhesus monkey ghrelin gene and factors influencing ghrelin gene expression and fasting plasma levels. Endocrinology 2004; 145(5):2197\u20132205.","journal-title":"Endocrinology"},{"issue":"9","key":"14_CR100","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1073\/pnas.091021198","volume":"98","author":"WR Oliver Jr","year":"2001","unstructured":"Oliver WR Jr, Shenk JL, Snaith MR et al. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA 2001; 98(9):5306\u20135311.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"14_CR101","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0378-1119(96)00796-2","volume":"188","author":"J Walston","year":"1997","unstructured":"Walston J, Lowe A, Silver K et al. The beta3-adrenergic receptor in the obesity and diabetes prone rhesus monkey is very similar to human and contains arginine at codon 64. Gene 1997; 188(2):207\u2013213.","journal-title":"Gene"},{"issue":"2","key":"14_CR102","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/en.2006-1168","volume":"148","author":"A Kharitonenkov","year":"2007","unstructured":"Kharitonenkov A, Wroblewski VJ, Koester A et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 2007; 148(2):774\u2013781.","journal-title":"Endocrinology"},{"issue":"3","key":"14_CR103","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1517\/13543784.15.3.243","volume":"15","author":"G Boden","year":"2006","unstructured":"Boden G, Zhang M. Recent findings concerning thiazolidinediones in the treatment of diabetes. Expert Opin Investig Drugs 2006; 15(3):243\u2013250.","journal-title":"Expert Opin Investig Drugs"},{"issue":"5579","key":"14_CR104","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1126\/science.1071527","volume":"297","author":"P Cohen","year":"2002","unstructured":"Cohen P, Miyazaki M, Socci ND et al. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 2002; 297(5579):240\u2013243.","journal-title":"Science"},{"issue":"7","key":"14_CR105","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/er.2006-0037","volume":"27","author":"C Handschin","year":"2006","unstructured":"Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis and metabolism. Endocr Rev 2006; 27(7):728\u2013735.","journal-title":"Endocr Rev"},{"issue":"2","key":"14_CR106","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cmet.2008.06.014","volume":"8","author":"C G\u00e4lman","year":"2008","unstructured":"G\u00e4lman C, Lund\u00e5sen T, Kharitonenkov A et al. The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. Cell Metab 2008; 8(2):169\u201374.","journal-title":"Cell Metab"},{"issue":"2","key":"14_CR107","doi-asserted-by":"publisher","first-page":"E251","DOI":"10.1152\/ajpendo.00401.2007","volume":"294","author":"M Bjursell","year":"2008","unstructured":"Bjursell M, Gerdin AK, Lelliott CJ et al. Acutely reduced locomotor activity is a major contributor to Western diet-induced obesity in mice. Am J Physiol Endocrinol Metab 2008; 294(2):E251\u2013E260.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"10","key":"14_CR108","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0022-2275(20)32207-0","volume":"42","author":"DA Winegar","year":"2001","unstructured":"Winegar DA, Brown PJ, Wilkison WO et al. Effects of fenofibrate on lipid parameters in obese rhesus monkeys. J Lipid Res 2001; 42(10):1543\u20131551.","journal-title":"J Lipid Res"},{"issue":"22","key":"14_CR109","doi-asserted-by":"publisher","first-page":"16638","DOI":"10.1074\/jbc.275.22.16638","volume":"275","author":"M Guerre-Millo","year":"2000","unstructured":"Guerre-Millo M, Gervois P, Rasp\u00e9 E et al. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem 2000; 275(22):16638\u201316642.","journal-title":"J Biol Chem"},{"issue":"1","key":"14_CR110","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler AE, Janson J, Bonner-Weir S et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52(1):102\u2013110.","journal-title":"Diabetes"},{"issue":"5","key":"14_CR111","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.2337\/db07-1476","volume":"57","author":"X Zhang","year":"2008","unstructured":"Zhang X, Yeung DC, Karpisek M et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 2008; 57(5):1246\u20131253.","journal-title":"Diabetes"},{"issue":"12","key":"14_CR112","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.2337\/db09-0713","volume":"58","author":"P Hojman","year":"2009","unstructured":"Hojman P, Pedersen M, Nielsen AR et al. Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia. Diabetes 2009; 58(12):2797\u2013801.","journal-title":"Diabetes"},{"issue":"2","key":"14_CR113","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.diabres.2008.07.012","volume":"82","author":"L Li","year":"2008","unstructured":"Li L, Yang G, Ning H et al. Plasma FGF-21 levels in type 2 diabetic patients with ketosis. Diabetes Res Clin Pract 2008; 82(2):209\u2013213.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"14_CR114","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1055\/s-2007-985148","volume":"116","author":"WW Chen","year":"2008","unstructured":"Chen WW, Li L, Yang GY et al. Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2008; 116(1):65\u201368.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"14_CR115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.33549\/physiolres.931801","volume":"59","author":"V Durovcov\u00e1","year":"2010","unstructured":"Durovcov\u00e1 V, Marek J, H\u00e1na V et al. Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing\u2019s syndrome. Physiol Res 2010; 59(3):415\u201322.","journal-title":"Physiol Res"},{"issue":"1","key":"14_CR116","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2337\/dc08-1054","volume":"32","author":"S Stein","year":"2009","unstructured":"Stein S, Bachmann A, L\u00f6ssner U et al. Serum levels of the adipokine FGF21 depend on renal function. Diabetes Care 2009; 32(1):126\u2013128.","journal-title":"Diabetes Care"},{"issue":"9","key":"14_CR117","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1210\/jc.2008-0746","volume":"93","author":"I Dost\u00e1lov\u00e1","year":"2008","unstructured":"Dost\u00e1lov\u00e1 I, Kav\u00e1lkov\u00e1 P, Haluz\u00edkov\u00e1 D et al. Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa. J Clin Endocrinol Metab 2008; 93(9):3627\u20133632.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"14_CR118","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1365-2362.2004.01344.x","volume":"34","author":"V Bartak","year":"2004","unstructured":"Bartak V, Vybiral S, Papezova H et al. Basal and exercise-induced sympathetic nervous activity and lipolysis in adipose tissue of patients with anorexia nervosa. Eur J Clin Invest 2004; 34(5):371\u2013377.","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"14_CR119","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.106.647503","volume":"115","author":"A Xu","year":"2007","unstructured":"Xu A, Tso AW, Cheung BM et al. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 2007; 115(12):1537\u20131543.","journal-title":"Circulation"},{"issue":"3","key":"14_CR120","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2265.2008.03502.x","volume":"71","author":"M Mraz","year":"2009","unstructured":"Mraz M, Bartlova M, Lacinova Z et al. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity. Clin Endocrinol (Oxf) 2009; 71(3):369\u2013375.","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Advances in Experimental Medicine and Biology","Endocrine FGFs and Klothos"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-0887-1_14.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:01:16Z","timestamp":1641052876000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4614-0887-1_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9781461408864","9781461408871"],"references-count":120,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-0887-1_14","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}